0001974158-24-000096.txt : 20241227
0001974158-24-000096.hdr.sgml : 20241227
20241227163350
ACCESSION NUMBER: 0001974158-24-000096
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20241227
DATE AS OF CHANGE: 20241227
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Enliven Therapeutics, Inc.
CENTRAL INDEX KEY: 0001672619
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811523849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39247
FILM NUMBER: 241586059
BUSINESS ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-647-8519
MAIL ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: IMARA Inc.
DATE OF NAME CHANGE: 20160419
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hohl Benjamin
CENTRAL INDEX KEY: 0001882764
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
144
1
primary_doc.xml
144
0001882764
XXXXXXXX
LIVE
0001672619
Enliven Therapeutics, Inc.
001-39247
6200 LOOKOUT ROAD
BOULDER
CO
80301
720-647-8519
Hohl Benjamin
Officer
Common
Jefferies LLC
520 Madison Ave
4th Fl
New York
NY
10022
4250
96517.50
49000000
12/27/2024
Nasdaq
Common
08/09/2022
Stock options
Enliven Therapeutics
N
4250
08/09/2022
N/A
N
Benjamin Hohl
6200 Lookout Rd
1st FL
Boulder
CO
80301
Enliven Therapeutics
11/27/2024
5250
130688.51
Benjamin Hohl
6200 Lookout Rd
1st FL
Boulder
CO
80301
Enliven Therapeutics
09/27/2024
4250
103160.97
Benjamin Hohl
6200 Lookout Rd
1st FL
Boulder
CO
80301
Enliven Therapeutics
09/30/2024
2000
50667.62
Benjamin Hohl
6200 Lookout Rd
1st FL
Boulder
CO
80301
Enliven Therapeutics
10/01/2024
521
14346.90
Benjamin Hohl
6200 Lookout Rd
1st FL
Boulder
CO
80301
Enliven Therapeutics
10/04/2024
10218
281078.79
Benjamin Hohl
6200 Lookout Rd
1st FL
Boulder
CO
80301
Enliven Therapeutics
10/07/2024
1270
34935.26
All Sales are to be made pursuant to a previously signed/adopted 10b5-1 Selling plan dated 06/26/2023, and all representations regarding material non-public information were made as of the adoption of the plan.
12/27/2024
Benjamin Hohl